Entity Address, City or Town
Entity Address, City or Town
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term
Lease renewal term
Entity Ex Transition Period
Entity Ex Transition Period
Fair Value Disclosures [Abstract]
Earnings Per Share [Abstract]
Denominator
AstraZeneca UK
Astrazeneca UK [Member]
Astrazeneca UK.
Payment of equity financing costs.
Payment of Equity Financing Costs
Equity financing costs
2021 Term Loan and Promissory Note One
Two Thousand Twenty One Term Loan and Promissory Note One [Member]
Two Thousand Twenty One Term Loan and Promissory Note One [Member]
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Liabilities
Direct costs and expenses.
Direct Costs And Expenses [Member]
Direct Costs and Expenses
Stock issuable per day, number of shares
Aggregate offering price
Issuance of common stock, net
Stock Issued During Period, Value, New Issues
Other Assets Policy Text Block
Other Assets Policy Text Block
Other Assets
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities
Purchase agreement term.
Purchase Agreement Term
Purchase agreement term
Intangible Assets, Gross (Excluding Goodwill)
Intangible assets, Cost
Intangible Assets, Gross (Excluding Goodwill), Total
Fair Value Measurement [Domain]
Fair Value Measurement
Long-term Line of Credit, Total
Long-Term Line of Credit
Long-term Line of Credit
Amendment Flag
Amendment Flag
2028 and thereafter
Long term debt maturities repayments of principal in year five and thereafter.
Long Term Debt Maturities Repayments Of Principal In Year Five And Thereafter
2027
Long-Term Debt, Maturity, Year Four
Capital Expenditures Incurred but Not yet Paid
Noncash purchases of property and equipment
Convertible Debt Securities [Member]
Convertible Debt
Subsequent Event Type [Domain]
Extinguishment of Debt [Axis]
Finite-Lived Intangible Assets, Accumulated Amortization
Intangible assets subject to amortization, Accumulated Amortization
Goodwill
Goodwill
Goodwill, Total
Goodwill, Beginning Balance
Goodwill, Ending Balance
Diagnostic tests.
Diagnostic Tests [Member]
Diagnostic Tests
Operating Lease, Right-of-Use Asset
Right of use assets
Operating lease right-of-use assets
Assets, Noncurrent [Abstract]
Non‑current assets
Notes Payable, Noncurrent
Long‑term notes payable, net of current portion
Notes Payable, Noncurrent, Total
Long-term notes payable
Document Quarterly Report
Document Quarterly Report
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Table]
Less amount representing interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Operating leases, Less amount representing interest
Share based compensation arrangement by share based payment award options granted aggregate intrinsic value.
Share Based Compensation Arrangement By Share Based Payment Award Options Granted Aggregate Intrinsic Value
Aggregate Intrinsic Value, Granted
To be paid on September 30, 2022
To Be Paid On September 30 2022 [Member]
To be paid on September 30 2022.
Statement [Table]
Statement [Table]
Operating Lease, Liability, Noncurrent
Long-term operating lease liabilities
Lessor reimbursements received
Lessor Reimbursements Received
Lessor reimbursements received.
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Issuance of common stock under employee stock purchase plan, Shares
Service [Member]
Services
Other Noncurrent Liabilities [Member]
Other Long-term Liabilities
Preferred Stock, Shares Outstanding
Preferred stock, outstanding
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Business Acquisition [Axis]
Business Acquisition
Common Stock, Capital Shares Reserved for Future Issuance
Number of shares reserved for issuance
Series B Preferred Stock [Member]
Series B Preferred Stock
Weighted Average Grant Date Fair Value Per Share, March 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance
Weighted Average Grant Date Fair Value Per Share, Released
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Maximum percentage of common stock allowed to purchase by counterparty.
Maximum Percentage of Common Stock Allowed to Purchase by Counterparty
Maximum percentage of common stock allowed to purchase by counterparty
First Amendment [Member]
First Amendment.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Stock Options, Forfeited/canceled
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total
Product and Service [Axis]
Product and Service
Employee Stock [Member]
Employee Stock Purchase Plan
Fourth milestone and interest payment made.
Fourth milestone and interest payment made
Fourth milestone payment and interest paid
Subscription agreements.
Subscription Agreements Member
Subscription Agreements
Second amendment.
Second Amendment [Member]
Second Amendment
Employee-related Liabilities, Current
Compensation related accruals
Employee-related Liabilities, Current, Total
Concentration Risk Type [Axis]
Concentration Risk Type
Operating Lease, Weighted Average Remaining Lease Term
Operating leases, Weighted-average remaining lease term (in years)
Total liabilities and stockholders' equity
Liabilities and Equity
Plan Name [Domain]
Plan Name
Number of Shares, Forfeited/canceled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Number of Shares, Forfeited/canceled
Other Liabilities, Current, Total
Other Liabilities, Current
Other current liabilities
Change in fair value of warrant liability
Change in fair value of warrant liability
Fair Value Adjustment of Warrants
Discount Rate
Measurement Input, Discount Rate [Member]
Minimum annual volume percentage thereafter.
Minimum Annual Volume Percentage Thereafter
Minimum annual volume percentage thereafter
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Income Statement [Abstract]
Board of Directors Chairman [Member]
Board of Directors
Operating leases, 2028 and thereafter
Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Lessee Operating Lease Liability Payments Due After Year Four
Tranche C Loan
Share-Based Payment Arrangement, Tranche Three [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Organization and Description of Business
Remaining estimated obligation.
Remaining Estimated Obligation
Remaining estimated obligation
Third amendment.
Third Amendment [Member]
Third Amendment
Sale of Stock [Domain]
Sale of Stock
Liabilities, Current
Total current liabilities
Lease agreement number of options to extend
Lease Agreement Number Of Options To Extend
Lease agreement number of options to extend
Percentage of royalty payments on net revenue.
Percentage Of Royalty Payments On Net Revenue
Percentage of royalty payments on net revenue
Stock Issued During Period, Value, Employee Stock Purchase Plan
Issuance of common stock under employee stock purchase plan
Series A-2 preferred stock.
Series A2 Preferred Stock [Member]
Series A2 Preferred Stock
Operating leases, 2026
Lessee, Operating Lease, Liability, to be Paid, Year Three
Cash Acquired from Acquisition
Business acquisition contingent consideration gross margin target
Business Acquisition, Acquiree [Domain]
Business Acquisition, Acquiree
United Healthcare
United Healthcare [Member]
United healthcare.
Fair Value, Recurring [Member]
Fair Value, Recurring
Interest expense
Interest Expense
Interest expense
Interest Expense, Total
Accounts Receivable, Allowance for Credit Loss
Allowance for doubtful accounts receivable
Accounts Receivable, Allowance for Credit Loss, Beginning Balance
Accounts Receivable, Allowance for Credit Loss, Ending Balance
Tranche B Loan
Share-Based Payment Arrangement, Tranche Two [Member]
Two Tranche
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Tenant improvement allowances received
Tenant Improvement Allowances Received
Tenant improvement allowances received.
Warrant liabilities
Warrant Liabilities Fair Value Disclosure
Warrant Liabilities Fair Value Disclosure
Common stock purchase agreement member.
Common Stock Purchase Agreement Member
Common Stock Purchase Agreement
Increase (Decrease) in Contract with Customer, Liability
Deferred revenue
Lessee, operating lease, liability, amount representing tenant improvement allowances.
Lessee, operating lease, liability, amount representing tenant improvement allowances
Operating leases, Less amount representing tenant improvement allowances
Preferred Stock, Shares Authorized
Preferred stock, authorized
Other Noncurrent Assets [Member]
Other Long-term Assets
Percentage of royalty payments on net sales.
Percentage Of Royalty Payments On Net Sales
Percentage of royalty payments on net sales
Long-Term Debt, Fair Value
Borrowings
Additional warratns exercisable
Class of Warrant or Right, Additional Warrants or Rights Exercisable
Class of warrant or right, additional warrants or rights exercisable.
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Operating Lease, Weighted Average Discount Rate, Percent
Operating leases, Weighted-average discount rate
Weighted-average remaining lease term and discount rate associated with operating leases
Funding amount
Proceeds from Issuance or Sale of Equity, Total
Proceeds from Issuance or Sale of Equity
Gross proceeds from sale of common shares
Proceeds from issuance of common stock under employee stock purchase plan.
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
Proceeds from issuance of common stock under employee stock purchase plan
Entity Small Business
Entity Small Business
Additional Tenant improvement allowance
Additional Tenant Improvement Allowance Amount
Additional tenant improvement allowance amount.
Cash and cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Cash, cash equivalents, and restricted cash ‑ end of period
Cash, cash equivalents, and restricted cash ‑ beginning of period
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Investments [Domain]
Investments
Series C Preferred Stock [Member]
Series C Preferred Stock
Debt Instrument, Redemption, Period [Domain]
Debt Instrument, Redemption, Period
Assets, Current
Total current assets
Property, Plant and Equipment [Line Items]
Property Plant And Equipment [Line Items]
Indefinite-Lived Intangible Assets [Axis]
Indefinite-lived Intangible Assets
Operating leases, Remainder of 2023
Operating leases, Remainder of 2022
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Intangible assets not subject to amortization, Net Carrying Value
Indefinite-lived Intangible Assets (Excluding Goodwill), Total
Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance
Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance
Summary Of Significant Accounting Policies [Line Items].
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Weighted-average shares outstanding, basic
City Area Code
City Area Code
Aggregate Intrinsic Value, Outstanding - March 31, 2023
Aggregate Intrinsic Value, Outstanding - January 1, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Percentage of development and regulatory costs exercised using opt-out right.
Percentage Of Development And Regulatory Costs Exercised Using Opt Out Right
Percentage of development and regulatory costs exercised using opt-out right
Share-Based Payment Arrangement [Abstract]
Liabilities
Total liabilities
Private Placement [Member]
Private Placement
Document Period End Date
Document Period End Date
Year of ending royalty payments from first commercial sale.
Year Of Ending Royalty Payments From First Commercial Sale
Year of ending royalty payments from first commercial sale
Payments for proceeds from patent costs and intangible asset acquisition, net.
Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net
Patent costs and intangible asset acquisition, net
Schedule of Finite-Lived Intangible Assets [Table]
Schedule Of Finite Lived Intangible Assets [Table]
Series E convertible preferred stock warrants.
Series E Convertible Preferred Stock Warrants [Member]
Series E Convertible Preferred Stock Warrants
Construction in Progress [Member]
Construction in Process
Weighted average lease term discount rate finance operating.
Weighted Average Lease Term Discount Rate Finance Operating [Table Text Block]
Weighted-average Lease Term and Discount Rates
Equity financing costs included in Accounts payable and other accrued liabilities
Equity Financing Costs Included in Accounts Payable and Other Accrued Liabilities
Equity financing costs included in Accounts payable and other accrued liabilities.
Tranche A Loan
Share-Based Payment Arrangement, Tranche One [Member]
First Tranche
Lease commencement Date
Lease Commencement Date
Lease commencement date
Software
Software and Software Development Costs [Member]
Contract with Customer, Liability, Noncurrent
Non-current deferred revenue
2024
Finite-Lived Intangible Asset, Expected Amortization, Year One
Statistical Measurement [Axis]
Statistical Measurement
Trademarks [Member]
Trademarks
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests.
Percentage Of Revenue Share Payment Related To Acquired Diagnostic Test Recognized Revenue For Non Screening Tests
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests
At-the-money facility.
At-the-money Facility [Member]
At-the-money Facility
Other Assets, Current
Other current assets
Schedule of Intangible Assets and Goodwill [Table Text Block]
Schedule of Intangible Assets, Excluding Goodwill
Subsequent Event [Line Items]
Shares issued or issuable, threshold limit description.
Shares Issued or Issuable, Threshold Limit Description
Shares issued or issuable, threshold limit description
Vehicles [Member]
Vehicles
Assets
Total assets
Series F Preferred Stock [Member]
Series F Preferred Stock
Securities purchase agreements.
Securities Purchase Agreements [Member]
Securities Purchase Agreement
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net loss per share, diluted
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Deposits [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Common Stock Equivalents Excluded from Diluted Net Loss Attributable to Common Stockholders
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Ending balances
Beginning balances
Exit fee payment.
Exit Fee Payment
Exit fee payment
Class of Stock Disclosures [Abstract]
Revenue share agreement.
Revenue Share Agreement [Member]
Revenue Share Agreement
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Document Fiscal Period Focus
Document Fiscal Period Focus
Revenue share expenses.
Revenue Share Expenses
Revenue share expenses
Bonus-to-options program.
Bonus To Options Program [Member]
Bonus-To-Options Program
Bio-rad license.
Bio Rad License [Member]
Bio-Rad License
Restricted Cash
Restricted cash
Restricted Cash, Total
Class of Warrant or Right [Table]
Class Of Warrant Or Right [Table]
Increase (Decrease) in Accounts Receivable
Accounts receivable
Deferred Offering Costs
Deferred offering costs
Preferred stock, $0.001 par value, 5,000,000 authorized; 0 (2023 and 2022) issued and outstanding
Preferred Stock, Value, Issued
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Ending Balance
Share-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Counterparty Name [Domain]
Counterparty Name
Other income, net
Other Nonoperating Income
Total lease liabilities
Operating Lease, Liability
Operating lease liability
Net cash and cash equivalents and restricted cash used in financing activities
Net Cash Provided by (Used in) Financing Activities
Landlord contribution towards cost of construction and tenant improvements
Landlord Contribution Towards Cost of Construction and Tenant Improvements
Landlord contribution towards cost of construction and tenant improvements
Notes Payable
Notes payable, total
Statement of Financial Position [Abstract]
Temporary Equity, Shares Issued
Convertible preferred stock, issued
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Changes in fair value
Entity File Number
Entity File Number
Scenario [Domain]
Statement of Cash Flows [Abstract]
Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Weighted average exercise price, Granted
Balance Sheet Related Disclosures [Abstract]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Warrant issued to purchase shares
Warrant issued to purchase shares
Deferred Revenue Arrangement Type [Axis]
Deferred Revenue Arrangement Type
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase shares of common stock
Warrant issued to purchase shares
Ficlatuzumab.
Ficlatuzumab [Member]
Ficlatuzumab
Class of Warrant or Right [Line Items]
Class Of Warrant Or Right [Line Items]
Geographical [Domain]
Statistical Measurement [Domain]
Statistical Measurement
Statement of Stockholders' Equity [Abstract]
Sale of Stock [Axis]
Sale of Stock
Notes Payable, Current
Less: current maturities
Notes Payable, Current, Total
Class of Stock [Domain]
Class of Stock
Loss Contingency Accrual, Beginning Balance
Loss Contingency Accrual, Ending Balance
Loss Contingency Accrual
Accrued legal contingency
Revenue Benchmark [Member]
Revenue
Lease, Cost [Table Text Block]
Summary of Components of Lease Expense
Stockholders' Equity Note [Abstract]
Subsequent Events [Abstract]
Fair Value Disclosures [Text Block]
Fair Value
Number of cancer test.
Number Of Cancer Test
Number of blood based lung cancer test
Weighted Average Contractual Life (Years), Exercisable - March 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Proceeds from Stock Options Exercised
Proceeds from exercise of stock options
Proceeds from Issuance of Common Stock
Proceeds from the sale of common shares
Net proceeds
Proceeds from the issuance of common stock
Business combination contingent consideration arrangements common shares redemption amount.
Business Combination Contingent Consideration Arrangements Common Shares Redemption Amount
Contingent consideration arrangements, common shares, redemption amount
Long-Term Debt, Type [Axis]
Long-term Debt, Type
Series G convertible preferred stock warrants.
Series G Convertible Preferred Stock Warrants [Member]
Series G Convertible Preferred Stock Warrants
Debt Instrument, Redemption, Period One [Member]
Prior to First Anniversary
Initial warrants amount
Initial warrants amount
Initial warrants amount.
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment
Reduction in contingent consideration
Reduction in contingent consideration
Proceeds from (Payments for) Other Financing Activities
Other
Revenue from Contract with Customer [Text Block]
Revenue and Accounts Receivable Credit Concentration
Concentrations of Credit Risk and Other Uncertainties
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Antidilutive Securities [Axis]
Antidilutive Securities
Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration]
Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Summary of Activity for Convertible Preferred Stock Warrants Outstanding
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Contract with Customer, Liability, Current
Deferred revenue
Remainder of 2023
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Lessee, Lease, Description [Line Items]
Supplemental Balance Sheet Disclosures [Text Block]
Supplementary Balance Sheet Information
Credit Facility [Domain]
Subsequent Events [Text Block]
Subsequent Events
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average shares outstanding, diluted
Cash Collateralized Letter of Credit
Cash Collateralized Letter of Credit [Member]
Cash collateralized letter of credit member.
Adjustments to additional paid-in capital deferred offering costs.
Adjustments to additional paid-in capital deferred offering costs
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name
Credit Facility [Axis]
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Remaining unrecognized share based compensation expense for options and restricted stock units
Portion at Fair Value Measurement [Member]
Fair Value Disclosure Item Amounts [Default]
Portion at Fair Value Measurement [Member] [Default]
Royalty Expense
Royalty expense
Computer Equipment [Member]
Computer Equipment
Inventory Supplies, Policy [Policy Text Block]
Inventory
Current Fiscal Year End Date
Current Fiscal Year End Date
Investment Type [Axis]
Investment Type
Industry Sector [Axis]
Industry Sector
Stock issued during period, shares, for deferred offering costs.
Stock Issued During Period, Shares, For Deferred Offering Costs
Issuance of common stock for deferred offering costs, Shares
PPP loan.
P P P Loan [Member]
PPP Loan
Liability Class [Axis]
Liability Class
Fourth amendment to 2021 term loan.
Fourth amendment to 2021 term loan [Member]
Fourth Amendment to 2021 Term Loan
Depreciation
Depreciation expense
Depreciation, Total
Financial Instruments [Domain]
Other Assets, Noncurrent
Other long-term assets
Other Assets, Noncurrent, Total
Entity Address, Address Line One
Entity Address, Address Line One
Amount used to retire outstanding debt
Repayments of Long-Term Debt
Repayment of term loan and notes payable
Repayments of Long-term Debt, Total
Series H Preferred Stock [Member]
Series H Convertible Preferred Stock
LPC facility.
L P C Facility [Member]
LPC Facility
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information:
Accounting Standards Update and Change in Accounting Principle [Text Block]
Recently Issued Accounting Standards
Percentage of interest on contingent consideration.
Percentage Of Interest On Contingent Consideration
Percentage of interest on installment payments
Contingent Consideration Type [Domain]
Contingent Consideration Type
Income Tax Expense (Benefit)
Provision for income taxes
Income Tax Expense (Benefit), Total
Public offering price per share of common stock
Public offering price per share of common stock
Public offering price per share of common stock.
Increase (Decrease) in Operating Lease Liability
Current and long-term operating lease liabilities
Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price.
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Weighted average exercise price, Outstanding - January 1, 2020, warrants
Weighted average exercise price, Outstanding - September 30, 2020, warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Forfeited/canceled
Income Tax Disclosure [Text Block]
Income Taxes
Vesting [Axis]
Preferred Stock, Shares Issued
Preferred stock, issued
Preferred Stock, Shares Issued, Total
Balance Sheet Location [Domain]
Balance Sheet Location
Other Accrued Liabilities, Current
Other expenses
Debt Instrument, Redemption, Period Two [Member]
Prior to Second Anniversary
Purchase of property and equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Purchases of property & equipment included in Accrued liabilities
Income Tax Disclosure [Abstract]
Business acquisition contingent consideration number of installments.
Business Acquisition Contingent Consideration Number Of Installments
Contingent consideration number of installments
Number of quarterly installment
Fourth milestone payment and interest.
Fourth milestone payment and interest
Fourth milestone payment and interest
Number of commercial blood based test.
Number Of Commercial Blood Based Test
Number of commercial blood-based test
Dividend Yield
Measurement Input, Expected Dividend Rate [Member]
Issuance of common stock, net, Shares
Stock Issued During Period, Shares, New Issues
Shares of common stock issued and sold
Leased property building capacity.
Leased Property Building Capacity
Leased property building capacity
Reported Value Measurement [Member]
Carrying Value
At The Market Offering [Member]
At The Market Offering [Member]
At-The-Market Offering
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Payment of deferred offering costs.
Payment Of Deferred Offering Costs
Deferred offering costs
Business combination contingent consideration final payment.
Business Combination Contingent Consideration Final Payment
Business combination contingent consideration final payment
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Summary of Future Minimum Lease Payments for Operating Lease Obligations
Contract with Customer, Liability, Revenue Recognized
Revenue recognized
Accounts Payable [Member]
Accounts Payable
Operating Income (Loss)
Loss from operations
Two thousand twenty one term loan.
Two Thousand Twenty One Term Loan [Member]
2021 Term Loan
Interest rate
Debt Instrument, Interest Rate, Stated Percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Shares issued
Number of Shares, Outstanding - March 31, 2023
Number of Shares, Outstanding - January 1, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Liabilities, Noncurrent
Total non‑current liabilities
Proceeds from issuance of term loan and notes payable.
Proceeds From Issuance Of Term Loan And Notes Payable
Proceeds from term loan and notes payable
Other member.
Other [Member]
Other
Payments to Acquire Businesses, Net of Cash Acquired
Contingent consideration cash payment
Payments to Acquire Businesses, Net of Cash Acquired, Total
Scenario [Axis]
Promissory note two.
Promissory Note Two [Member]
Promissory Note Two
At the market facility.
At The Market Facility [Member]
At-The-Market Facility
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark
Business acquisition contingent consideration gross margin target period.
Business Acquisition Contingent Consideration Gross Margin Target Period
Business acquisition contingent consideration gross margin target period
Class of Warrant or Right [Domain]
Class of Warrant or Right
Entity Filer Category
Entity Filer Category
Liabilities, Noncurrent [Abstract]
Non‑current liabilities
Tenant Improvements
Capital expenditure for leasehold improvements related to leases premises which are tenant improvements
Stock issued during period, values, for deferred offering costs.
Stock Issued During Period, Values, For Deferred Offering Costs
Issuance of common stock for deferred offering costs
Operating Expenses
Total operating expenses
Fair Value by Liability Class [Domain]
Fair Value by Liability Class
Entity Current Reporting Status
Entity Current Reporting Status
Additional warrants amount
Additional warrants amount
Additional warrants amount.
Fair value measurement with unobservable inputs interest expense.
Fair Value Measurement With Unobservable Inputs Interest Expense
Interest expense
Accrued interest, amortization of debt issuance costs and other.
Accrued Interest Amortization Of Debt Issuance Costs And Other
Accrued interest, amortization of debt issuance costs and other
Aggregate Intrinsic Value, Exercisable - March 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false]
Lease option to extend
Current portion of contingent consideration.
Current Portion Of Contingent Consideration [Member]
Current Portion of Contingent Consideration
Stockholders' Equity Note Disclosure [Text Block]
Equity
Finite-Lived Intangible Assets, Net
Intangible assets subject to amortization, Net Carrying Value
Finite-Lived Intangible Assets, Net, Beginning Balance
Finite-Lived Intangible Assets, Net, Ending Balance
Intangible assets subject to amortization, Net Carrying Value
Total stockholders' equity
Stockholders' Equity Attributable to Parent
Balances
Balances
Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842
Operating Lease Right-of-Use Assets Obtained in Exchange for Lease Liabilities at Adoption of ASC 842
Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842.
Shares issued as commitment fee, value.
Shares Issued as Commitment Fee, Value
Shares issued as commitment fee, value
2025
Long-Term Debt, Maturity, Year Two
Entity Tax Identification Number
Entity Tax Identification Number
Income Statement Location [Axis]
Income Statement Location
Common stock, $0.001 par value, 200,000,000 shares authorized 7,979,376 (2023) and 77,614,358 (2022) shares issued and outstanding
Common Stock, Value, Issued
Common Stock, Value, Issued, Total
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Ending Balance
Aggregate market value of common stock and other equity securities
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Ending Balance
Inventory Valuation Reserves
Reserve for inventory
Equipment [Member]
Lab Equipment
Disclosure of information about liabilities measured at fair value on recurring basis.
Fair Value Liabilities Measured On Recurring Basis [Table]
Fair Value Liabilities Measured On Recurring Basis [Table]
Equity Components [Axis]
Equity Components
Unamortized debt discount and debt issuance costs
OID and debt issuance costs
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Series E Preferred Stock [Member]
Series E Preferred Stock
Number of preferred stock converted into common stock.
Number Of Preferred Stock Converted Into Common Stock
Number of preferred stock converted into common stock
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Notes payable 2018 notes.
Notes Payable2018 Notes [Member]
2018 Notes
Tenant improvement allowances expected to be received
Tenant improvement allowances expected to be received.
Leases [Abstract]
Promissory Notes
Promissory Notes Member
Promissory notes.
Debt Instruments [Abstract]
Disaggregation of Revenue [Table]
Disaggregation Of Revenue [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Warrants expiration date
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accounts payable and other accrued liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Entity Emerging Growth Company
Entity Emerging Growth Company
Purchase Commitment, Excluding Long-Term Commitment [Domain]
Operating Expenses [Abstract]
Operating expenses:
Direct costs and expenses.
Direct Costs And Expenses
Direct costs and expenses
Volatility
Measurement Input, Price Volatility [Member]
Percentage of fee payments on net sales.
Percentage Of Fee Payments On Net Sales
Percentage of fee payments on net sales
CARES act.
C A R E S Act [Member]
CARES Act
Schedule of Stock by Class [Table]
Schedule Of Stock By Class [Table]
Letter of Credit [Member]
Letter of Credit
Two Thousand and Twenty One Term Loan Partial Repayment in April 2022 [Member]
2021 Term Loan Partial Repayment in April 2022
2021 Term Loan partial repayment in April 2022 member.
Percentage of license income generated from licensing.
Percentage Of License Income Generated From Licensing
Percentage of license income generated from licensing
Percentage of license income generated from licensing
Lessee, Operating Lease, Liability, to be Paid [Abstract]
COLORADO
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction, Total
Document Transition Report
Document Transition Report
2026
Long-Term Debt, Maturity, Year Three
Third Amendment to 2021 Term Loan [Member]
Third Amendment to 2021 Term Loan
Third amendment to 2021 term loan member.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Per Share, Granted
Indefinite lived intangible assets excluding goodwill gross.
Indefinite Lived Intangible Assets Excluding Goodwill Gross
Intangible assets not subject to amortization, Cost
Percentage of development and regulatory costs.
Percentage Of Development And Regulatory Costs
Responsible percentage of development and regulatory costs
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Exercised
Accounts receivable, net of allowance for doubtful accounts of $200 and $118
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Number of facility.
Number of Facility
Number of facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Description of offering period under plan.
Description Of Offering Period Under Plan
Description of offering period under plan
Loss member.
Loss [Member]
Loss
Net Income (Loss) Attributable to Parent
Net loss
Net loss
Net loss attributable to common stockholders
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Operating Lease, Liability, Current
Current portion of operating lease liabilities
Number of SARS-CoV-2 test.
Number Of S A R S Co V2 Test
Number of SARS-CoV-2 test
Two thousand twenty one term loan principal repayment.
Two Thousand Twenty One Term Loan Principal Repayment [Member]
2021 Term Loan Principal Repayment
Base rent per month from commencement date.
Base Rent Per Month From Commencement Date
Base rent per month from commencement date
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Summary of Restricted Stock Units Activity
Initial fairvalue of additional warrants
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Schedule of Maturities of Long-Term Debt [Table Text Block]
Scheduled Principal Repayments (Maturities) of Long-term Obligations
Contingent consideration.
Contingent Consideration [Member]
Contingent Consideration
Entity Registrant Name
Entity Registrant Name
Liabilities, Fair Value Disclosure
Total contingent consideration
Liabilities, Fair Value Disclosure, Total
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Earnings Per Share [Text Block]
Net Loss per Common Share
Estimated payment to third parties.
Estimated Payment To Third Parties
Estimated payment to third parties
Class of Stock [Axis]
Convertible Preferred Stock
Debt Instrument, Maturity Date
Debt instrument maturity date
Lessee, Lease, Description [Table]
Revenues
Revenues
Revenues, Total
Share-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Share-based Payment Arrangement, Noncash Expense, Total
Property, Plant and Equipment, Net
Property and equipment, net
Total property and equipment, net
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Ending Balance
Debt instrument, discount
Debt Instrument, Unamortized Discount
Debt Instrument, Unamortized Discount, Total
Award Type [Domain]
Award Type
Statement [Line Items]
Statement [Line Items]
Series A-3 preferred stock.
Series A3 Preferred Stock [Member]
Series A3 Preferred Stock
Operating Lease, Expense
Operating lease expense
Warrant Liabilities
Warrant Liability
Warrant Liability [Member]
Warrant liability.
Accounting Standards Update and Change in Accounting Principle [Abstract]
Title of 12(b) Security
Title of 12(b) Security
Finite-Lived Intangible Assets, Gross
Intangible assets subject to amortization, Cost
Finite-Lived Intangible Assets, Gross, Total
Common Stock [Member]
Common Stock
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Restricted Cash
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities
Equity Component [Domain]
Equity Component
Fair Value Measurement, Policy [Policy Text Block]
Fair Value of Financial Instruments
Convertible Preferred Stock [Member]
Convertible Preferred Stock
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
Entity Address, State or Province
Entity Address, State or Province
Operating leases, 2027
Lessee, Operating Lease, Liability, to be Paid, Year Four
Geographical [Axis]
Net decrease in cash and cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Document Type
Document Type
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activities
Warrants for convertible preferred stock.
Warrants For Convertible Preferred Stock [Text Block]
Warrants to Purchase Convertible Preferred Stock
Lease expiration month year
Lease Expiration Month Year
Lease expiration date
Entity Shell Company
Entity Shell Company
Collateral Held [Domain]
Share-Based Payment Arrangement, Expense
Stock compensation expense
Total share-based compensation expense
Percentage of royalty payments not required to pay on net revenue.
Percentage Of Royalty Payments Not Required To Pay On Net Revenue
Percentage of royalty payments not required on net revenue
Other Inventory, Supplies, Gross
Inventory
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Sale of stock, stock issuable per day, shares.
Sale of Stock, Stock Issuable Per Day, Shares
Stock issuable per day, number of shares
Operating Leases, Rent Expense, Net
Rent expense
Operating Leases, Rent Expense, Net, Total
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Security Exchange Name
Security Exchange Name
Revenue from Contract with Customer [Abstract]
Class of Stock [Line Items]
Class Of Stock [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Net cash and cash equivalents and restricted cash used in operating activities
Net Cash Provided by (Used in) Operating Activities
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Amortized to expense period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Contractual Life (Years), Outstanding
Effective interest rate
Debt Instrument, Interest Rate, Effective Percentage
Interest expense due to passage of time and fixed payment schedule
Interest expense due to passage of time and fixed payment schedule.
Commitments and Contingencies Disclosure [Abstract]
Centennial Valley Properties I, LLC Lease Agreement.
Centennial Valley Properties I, LLC Lease Agreement [Member]
Centennial Valley Properties I, LLC
Centennial Valley Properties I, LLC Lease Agreement
Expected Term
Measurement Input, Expected Term [Member]
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units (RSUs)
Restricted Stock Units
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Summary of Future Minimum Lease Payments for Operating Leases
Tenant improvements incurred during the period
Tenant Improvements Incurred During The Period
Tenant improvements incurred during the period.
Warrant [Member]
Warrants
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of Stock Option Activity
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted Accounting Standards
Common Stock, Shares, Outstanding
Common stock, outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Loss on debt extinguishment
Gain (Loss) on Extinguishment of Debt
Gain (Loss) on Extinguishment of Debt, Total
(Loss) gain on extinguishment of liabilities, net
Loss (gain) on extinguishment of liabilities, net
Loss on extinguishment of liabilities
Debt Disclosure [Text Block]
Debt
Term of royalty payments from first commercial sale.
Term Of Royalty Payments From First Commercial Sale
Term of royalty payments from first commercial sale
Subscription agreements description.
Subscription Agreements Description
Subscription agreements description
Deferred offering costs included in accrued liabilities.
Deferred Offering Costs Included In Accrued Liabilities
Deferred offering costs included in Accrued liabilities
Fair Value, Inputs, Level 2 [Member]
Level 2
2020 equity incentive plan.
Two Thousand Twenty Equity Incentive Plan [Member]
2020 Equity Incentive Plan
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities
Options and restricted stock units (RSUs).
Options And Restricted Stock Units R S Us [Member]
Options and Restricted Stock Units (RSUs)
Promissory note one.
Promissory Note One [Member]
Promissory Note One
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Schedule of Future Estimated Amortization Expense of Intangible Assets
Commitments and Contingencies
Commitments and contingencies
Common Stock, Shares, Issued
Common stock, issued
Common Stock, Shares, Issued, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Exercised, warrants
Common stock issued for deferred offering costs.
Common Stock Issued For Deferred Offering Costs
Common stock issued for deferred offering costs
Minimum [Member]
Minimum
Debt Instrument, Redemption, Period Three [Member]
After Second Anniversary, Prior to October 19, 2025
Rent after fixed escalation provisions.
Rent After Fixed Escalation Provisions
Rent after fixed escalation provisions
Loss Contingency Accrual, Payments
Final settlement payment of legal contingency
Restricted Cash, Current
Restricted cash deposits
Net proceeds from debt, after deducting debt issuance costs and expenses
Proceeds from Debt, Net of Issuance Costs
Proceeds from net of debt issuance costs and original issue discounts
Patents [Member]
Patents
Leases
Lessee, Leases [Policy Text Block]
Weighted Average Exercise Price, Exercisable - March 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Accrued Liabilities, Current
Accrued liabilities
Total accrued liabilities
Weighted Average Grant Date Fair Value Per Share, January 1, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Deferred Revenue [Domain]
Deferred Revenue
Debt Instrument [Axis]
Debt Instrument
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' equity
Counterparty Name [Axis]
Counterparty Name
Entity Address, Address Line Two
Entity Address, Address Line Two
Percentage of probabilities of contingent consideration successful achievement milestone discount rates range.
Percentage Of Probabilities Of Contingent Consideration Successful Achievement Milestone Discount Rates Range
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Per Share, Forefeited/canceled
Lessee, Operating Lease, Lease Not yet Commenced, Description
Lease description
Amortization of Intangible Assets
Amortization expense of definite-lived intangible assets
Amortization of Intangible Assets, Total
Award Type [Axis]
Award Type
Subsequent Event [Member]
Subsequent Event
Loss Contingencies [Table]
Loss Contingencies [Table]
Milestone payment.
Milestone payment
Total other expense
Other Nonoperating Income (Expense)
Maturities of Long-Term Debt [Abstract]
Options to purchase common stock.
Options To Purchase Common Stock [Member]
Options to Purchase Common Stock
Organization and description of business.
Organization And Description Of Business [Abstract]
Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received.
Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received
Payments of contingent consideration
Fair value measurement with unobservable inputs payments of contingent consideration.
Fair Value Measurement with Unobservable Inputs Payments of Contingent Consideration
Payments of contingent consideration
Proceeds from Issuance of Private Placement
Aggregate purchase price
Private placement in net equity proceeds
Cash collateralized.
Cash Collateralized [Member]
Cash Collateralized
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]
Summary of Fair Value of Outstanding Borrowings
Research and Development Expense
Research and development
Research and Development Expense, Total
Lessee, Operating Lease, Liability, to be Paid
Operating leases, Total future minimum lease payments
Payment for Contingent Consideration Liability, Financing Activities
Payment of contingent consideration
Lessee, Operating Lease, Term of Contract
Operating lease, expiration term
Entity Central Index Key
Entity Central Index Key
Other Income and Expenses [Abstract]
Other (expense) income:
Lincoln Park.
Lincoln Park Member
Lincoln Park
Warrants and Rights Outstanding, Maturity Date
Warrants, expires period
CellCarta License.
Cell Carta License [Member]
CellCarta License
Business Combination, Contingent Consideration, Liability, Noncurrent
Contingent consideration
Finite-Lived Intangible Assets [Line Items]
Finite Lived Intangible Assets [Line Items]
Schedule of Future Minimum Rental Payments for Operating and Finance Leases
Summary of Future Minimum Rental Payments for Operating and Financing Leases
Summary of Future Minimum Lease Payments for Operating and Finance Leases
Schedule of future minimum Rental payments for operating and finance leases.
Net Income (Loss) Attributable to Parent [Abstract]
Numerator
Preferred Stock [Text Block]
Convertible Preferred Stock
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Finance lease right-of-use assets obtained in exchange for lease liabilities
Customer [Axis]
Customer
Accounting Policies [Abstract]
Interest-Bearing Deposits [Member]
Interest-bearing Deposits
Debt Instrument, Redemption, Period [Axis]
Debt Instrument, Redemption, Period
Disaggregation of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less: accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Property, Plant and Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Supplemental cash flow information leases operating and finance.
Supplemental Cash Flow Information Leases Operating and Finance [Table Text Block]
Supplemental Cash Flow Information Associated with Leasing Activities
Third amendment to APA agreement member.
Third Amendment to APA Agreement [Member]
Third Amendment to APA Agreement
Measurement Frequency [Axis]
Measurement Frequency
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Common stock remained available for future issuance
Share-Based Payment Arrangement [Text Block]
Share-Based Compensation
Accretion of lease liability
Accretion Of Lease Liability
Accretion of lease liability.
Business Combination, Contingent Consideration, Liability, Current
Current portion of contingent consideration
Subsequent Event [Table]
Period of escalations of sales.
Period Of Escalations Of Sales
Period of escalations of sales
Measurement Input Type [Domain]
Weighted Average Exercise Price, Outstanding - March 31, 2023
Weighted Average Exercise Price, Outstanding - January 1, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Research and Development Expense [Member]
Research and Development
Increase (Decrease) in Other Current Assets
Other current assets
Warrants and rights outstanding, measurement input
Warrants and Rights Outstanding, Measurement Input
Lessee operating and finance leases.
Lessee Operating and Finance Leases [Text Block]
Leases
Forecast [Member]
Scenario Forecast
Notes Payable to Bank, Current
Current portion of notes payable
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Operating lease right-of-use assets obtained in exchange for lease liabilities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities
Retained Earnings [Member]
Accumulated Deficit
Series B-1 Convertible Preferred Stock.
Series B1 Convertible Preferred Stock [Member]
Series B1 Convertible Preferred Stock
Extinguishment of Debt, Type [Domain]
Proceeds from issuance of common stock net.
Proceeds From Issuance Of Common Stock Net
Net proceeds from sale of common shares after deducting underwriting discounts and commissions and offering expenses
Net proceeds
License agreement expiry date.
License Agreement Expiry Date
License expiry date
Customer [Domain]
Customer
Segment Reporting [Abstract]
Principal repayment member.
Principal Repayment [Member]
Principal Repayment
Deferred issuance costs included in Accounts payable and other accrued liabilities
Debt Issuance Costs Included in Accounts Payable and Other Accrued Liabilities
Debt issuance costs included in Accounts payable and other accrued liabilities.
Measurement Input Type [Axis]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Industry Sector [Domain]
Industry Sector
Property, Plant and Equipment, Gross
Property and equipment, gross
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Ending Balance
Series D Preferred Stock [Member]
Series D Preferred Stock
Area of office space leased.
Area of Office Space Leased
Area of office space leased
Additional Paid in Capital
Additional paid‑in capital
Additional Paid in Capital, Total
Additional Paid in Capital, Beginning Balance
Additional Paid in Capital, Ending Balance
Entity Interactive Data Current
Entity Interactive Data Current
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract
Lease term
KANSAS
Operating leases, 2024
Operating leases, 2023
Lessee, Operating Lease, Liability, to be Paid, Year One
existing shareholders.
existing shareholders member
Shareholders
Existing Shareholders
Prepayment premium percentage of aggregate outstanding principal amount
Prepayment premium percentage of aggregate outstanding principal amount
Prepayment premium percentage of aggregate outstanding principal amount.
Accounts Receivable, Credit Loss Expense (Reversal)
Provision for doubtful accounts
Leasehold Improvements [Member]
Leasehold Improvements
Temporary Equity, Shares Outstanding
Temporary Equity Balance, Shares
Temporary Equity Balance, Shares
Convertible preferred stock, outstanding
Local Phone Number
Local Phone Number
Repurchase.
Repurchase [Member]
Repurchase
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Computation of Basic and Diluted Loss per Share Attributable to Stockholders
Debt Disclosure [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Share based compensation arrangement by share based payment award non-options forfeitures and expirations in period weighted average exercise price.
Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Weighted average exercise price, Forfeited/canceled
Stock Options Exercisable - March 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Lessee, Operating Lease, Description
Description of lease
Warrants and Rights Note Disclosure [Abstract]
IPO [Member]
Initial Public Offering
IPO
Disaggregation of Revenue [Table Text Block]
Summary of Revenue
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Stock Options, Granted
Other Liabilities, Noncurrent
Other long-term liabilities
Other Liabilities, Noncurrent, Total
Schedule of Changes in Contingent Consideration and Warrant Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split ratio
Other Current Assets [Member]
Other Current Assets
Amount of accumulated amortization of intangible assets, excluding goodwill.
Intangible Assets Accumulated Amortization Excluding Goodwill
Intangible assets, Accumulated Amortization
Income Statement Location [Domain]
Income Statement Location
Interest rate on extra allowance amount
Interest Rate on Extra Allowance Amount
Interest rate on extra allowance amount
Risk-Free Interest Rate
Measurement Input, Risk Free Interest Rate [Member]
2024
Long-Term Debt, Maturity, Year One
Selling, General and Administrative Expenses [Member]
Sales, Marketing, General and Administrative
Assets, Noncurrent
Total non‑current assets
Total
Long-Term Debt
Shares, Outstanding
Common Stock Balance, Shares
Common Stock Balance, Shares
Line of Credit Facility, Remaining Borrowing Capacity
Remaining available capacity for share issuance
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Debt Instrument, Redemption, Period Four [Member]
Thereafter
Contingent Consideration by Type [Axis]
Contingent Consideration by Type
Customer Concentration Risk [Member]
Customer Concentration Risk
Operating Expense [Member]
Operating Expense
Stock Options, Outstanding - March 31, 2023
Stock Options, Outstanding - January 1, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share Price
Price per share
Perceptive Term Loan Facility
Perceptive Term Loan Facility
Perceptive Term Loan [Member]
Perceptive term loan member.
Schedule of Reported Fair values of Contingent Consideration and Warrant Liabilities
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Debt Instrument, Name [Domain]
Debt Instrument, Name
Shares committed under ESPP.
Shares Committed Under E S P P [Member]
Shares Committed Under ESPP
Document Fiscal Year Focus
Document Fiscal Year Focus
Intangible Assets, Net (Excluding Goodwill)
Intangible assets, net
Intangible assets, Net Carrying Value
Repayments of Debt
Repayments of Debt
Repayments of debt
Class of Warrant or Right [Axis]
Class of Warrant or Right
Payments of Debt Issuance Costs
Payment of debt issuance costs
Operating leases, 2025
Lessee, Operating Lease, Liability, to be Paid, Year Two
Vesting [Domain]
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Net loss per share, basic
Income Taxes Paid
Cash paid for income taxes
Assets [Abstract]
Assets
Aggregate principal amount outstanding
Debt Instrument, Annual Principal Payment
Schedule of Long-Term Debt Instruments [Table Text Block]
Summary of Long-term Notes Payable
Debt Instrument, Face Amount
Debt instrument, aggregate principal amount
Integrated diagnostics asset purchase agreement member.
Integrated Diagnostics Asset Purchase Agreement [Member]
Integrated Diagnostics Asset Purchase Agreement
Litigation claims and assessments.
Litigation Claims And Assessments [Member]
Litigation Claims and Assessments
Financial Instrument [Axis]
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark
Liabilities and Equity [Abstract]
Liabilities and Stockholders' (Deficit) Equity
Impairment of Intangible Assets, Finite-Lived
Impairment loss on intangible assets
Income Taxes Paid, Net
Cash paid for income taxes
Income Taxes Paid, Net, Total
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Aveo oncology.
A V E O Oncology [Member]
AVEO Oncology
Integrated Diagnostics, Inc.
Integrated Diagnostics Inc [Member]
Integrated Diagnostics, Inc
Assets, Current [Abstract]
Current assets
2027
Finite-Lived Intangible Asset, Expected Amortization, Year Four
2025
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant, exercise price
Warrant, exercise price
Business combination contingent consideration shares.
Business Combination Contingent Consideration Shares
Contingent consideration shares
Customer Funds
Refundable deposit
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Commitment shares issuable on conditional basis.
Commitment Shares Issuable on Conditional Basis
Commitment shares issuable on conditional basis
Excess and obsolete inventory
Inventory Write-down
Inventory excess and obsolescence
Measurement Frequency [Domain]
Measurement Frequency
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted
Granted, warrants
Number of Shares, Granted
Area of leased premised obligated to pay base rent.
Area of Leased Premised Obligated to Pay Base Rent
Area of leased premised obligated to pay base rent
Sale of Stock, stock issuable per day, value.
Sale of Stock, Stock Issuable Per Day, Value
Stock issuable per day, value
Diligence expenses and legal fees
Diligence Expense and Legal Fees
Diligence expense and legal fees.
Cover [Abstract]
Concentration Risk, Percentage
Concentration risk, percentage
Product and Service [Domain]
Product and Service
Accrued clinical trial expense current.
Accrued Clinical Trial Expense Current
Accrued clinical trial expense
Measurement Basis [Axis]
Measurement Basis
Release of restricted stock units, shares
Number of Shares, Released
Number of Shares, Released
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Liabilities, Current [Abstract]
Current liabilities
Up-front Payment Arrangement [Member]
Up Front Cash Payments
Sale of stock, shares issued as commitment fee.
Sale of Stock, Shares Issued as Commitment Fee
Shares issued as commitment fee
Maximum [Member]
Maximum
Maximum
Warrants expected term
Warrants and Rights Outstanding, Term
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Share-based Compensation Expense
Series G Preferred Stock [Member]
Series G Preferred Stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Forfeited/canceled, warrants
Net cash and cash equivalents and restricted cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Furniture and Fixtures [Member]
Furniture and Fixtures
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Exercise of stock options, shares
Stock Options, Exercised
Collateral Held [Axis]
Fair Value, Inputs, Level 3 [Member]
Level 3
Primary sources of revenue description.
Primary Sources Of Revenue Description
Primary sources of revenue, description
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Purchased technology.
Purchased Technology [Member]
Purchased Technology
Applicable margin rate
Debt Instrument, Basis Spread on Variable Rate
Purchase Commitment, Excluding Long-Term Commitment [Axis]
Accounts Receivable [Member]
Accounts Receivable
Remainder of 2023
Long-Term Debt, Maturity, Remainder of Fiscal Year
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options
Business Acquisition, Description of Acquired Entity
Business acquisition description
Weighted average price per share
Weighted Average Price Per Share
Weighted average price per share.
Long-Term Debt, Gross
Notes/Loan payable
2026
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Common Stock, Shares Authorized
Common stock, authorized
Nsclc poc trial.
N S C L C P O C Trial [Member]
NSCLC POC Trial
2021 term loan partial repayment.
2021 Term Loan Partial Repayment [Member]
2021 Term Loan Partial Repayment
Trading Symbol
Trading Symbol
2028 and thereafter
Finite lived intangible assets amortization expense year five and thereafter.
Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter
Stock issuable during period, value, committed shares.
Stock Issuable During Period, Value, Committed Shares
Common stock issuable, committed to purchase
Interest Expense [Member]
Interest Expense
Two Thousand Twenty One Term Loan Amendment.
Two Thousand Twenty One Term Loan Amendment [Member]
2021 Term Loan Amendment
Selling, General and Administrative Expense
Sales, marketing, general and administrative
Selling, General and Administrative Expense, Total
Title of Individual [Domain]
Subsequent Event Type [Axis]
Share based compensation arrangements by share based payment award non options exercises in period weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Weighted average exercise price, Exercised
Operating Lease, Right-of-Use Asset, Amortization Expense
Amortization of operating lease right-of-use assets
Amortization of lease right-of-use assets
Balance Sheet Location [Axis]
Balance Sheet Location
Accounts Payable, Current
Accounts payable
Accounts Payable, Current, Total
Perceptive Term Loan Facility
Perceptive Term Loan Facility [Member]
Perceptive term loan facility.
Plan Name [Axis]
Plan Name
Title of Individual [Axis]
Concentration Risk Type [Domain]
Concentration Risk Type
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset
Equity Financing Programs.
Equity Financing Programs [Member]
Equity Financing Programs
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers
Common Stock, Par or Stated Value Per Share
Common stock, par value
Deferred offering costs amortized against additional paid-in capital.
Deferred Offering Costs Amortized Against Additional Paid-In Capital
Deferred offering costs amortized against Additional paid-in capital
Medicare.
Medicare [Member]
Medicare
Minimum cash balance at maturity date
Minimum cash balance at maturity date
Minimum cash balance at maturity date.
Series A-1 preferred stock.
Series A1 Preferred Stock [Member]
Series A-1 Preferred Stock
Oncimmune Limited.
Oncimmune Limited [Member]
Oncimmune Limited
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Granted
Estimate of Fair Value Measurement [Member]
Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Restricted stock units outstanding
Number of Shares, Outstanding - January 1, 2022
Number of Shares, Outstanding - March 31, 2022
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Long-Term Debt, Type [Domain]
Long-term Debt, Type
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total
Concentration Risk [Table]
Concentration Risk [Table]
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Indefinite-lived Intangible Assets, Major Class Name
Increase (Decrease) in Other Noncurrent Assets
Other long-term assets